跳至主要内容
临床试验/TCTR20220628003
TCTR20220628003已完成1 期

The Efficacy of Tele-monitoring And Structured Feedback Loop in People with Insulin-treated Type 2 Diabetes Mellitus with Suboptimal Control

Roche0 个研究点目标入组 147 人开始时间: 2022年6月28日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
Roche
入组人数
147

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • 1. Age 18-65
  • 2. Has been diagnosed with type 2 diabetes for more than 6 months.
  • 3. Hemoglobin A1C levels were between 7.5-10% within 6 weeks prior to participating in the study.
  • 4. Get Insulin Treatment (either alone or in combination with other oral medications) for at least 3 months

排除标准

  • 1. Can't penetrate fingertip sugar
  • 2. There is no mobile phone that supports applications and data transmission via the Internet
  • 3. Unable to communicate with the researcher according to the research plan
  • 4. People with a history of taking other drugs that affect glucose levels within 3 months before participating in the study as follows Steroid, Vitamin C excluding vitamin C from natural or fruit sources, Vitamin E, Bactrim, Hydroxyurea
  • History of diabetic ketoacidosis, hyperglycemic hyperosmolar state in the past 6 months
  • 6. The patient was diagnosed with psychiatric disorders such as depression, bipolar disorder, and schizophrenia.
  • 7. Pregnant or planning to become pregnant within 12 months or breastfeeding
  • 8. Based on the history and clinical manifestations recorded in the medical record Patients with the following chronic diseases Chronic renal failure with a glomerular filtration rate of less than 30 ml/min/1.73 m2, cirrhosis or hepatitis with alanine aminotransferase or aspartate aminotransferase 3 times the upper limit of normal, alcoholism, hypothyroidism with Thyroid values. stimulating hormone greater than 10 uIU/ml, HIV infection, anemia with hemoglobin less than 10 g/dL, iron deficiency, vitamin B12 deficiency, folic acid deficiency, thalassemia, Enzyme Depletion glucose-6-phosphate dehydrogenase, hemolysis and hemoglobin greater than 16 g/dL
  • 9. Have a history of donating blood or received blood in the past 3 months
  • 10. According to medical records, there was uncontrolled diabetic retinopathy or maculopathy.
  • 11. Signs or history of cancer in the 5 years prior to the screening date except for basal cell, squamous cell, and other in situ carcinomas
  • 12. Has a history of major surgery within 90 days or plans to have a major surgery within 6 months

研究者

发起方
Roche

相似试验